BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Di Sessa A, Umano GR, Cirillo G, Passaro AP, Verde V, Cozzolino D, Guarino S, Marzuillo P, Miraglia del Giudice E. Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant. World J Gastroenterol 2020; 26(36): 5474-5483 [PMID: 33024398 DOI: 10.3748/wjg.v26.i36.5474]
URL: https://www.wjgnet.com/1948-5182/full/v26/i36/5474.htm
Number Citing Articles
1
Reham Mohammed Dawood, Ghada Maher Salum, Mai Abd El-Meguid, Basma EL-sayed Fotouh. Molecular Insights of Nonalcoholic Fatty Liver Disease PathogenesisJournal of Interferon & Cytokine Research 2024;  doi: 10.1089/jir.2023.0162
2
Shan Tang, Jing Zhang, Ting-Ting Mei, Wen-Yan Zhang, Su-Jun Zheng, Hai-Bin Yu. Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysisBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02067-y
3
Anna Di Sessa, Stefano Guarino, Antonio Paride Passaro, Laura Liguori, Giuseppina Rosaria Umano, Grazia Cirillo, Emanuele Miraglia Del Giudice, Pierluigi Marzuillo. NAFLD and renal function in children: is there a genetic link?Expert Review of Gastroenterology & Hepatology 2021; 15(9): 975 doi: 10.1080/17474124.2021.1906649
4
Dan-Qin Sun, Ting-Yao Wang, Kenneth I. Zheng, Hao-Yang Zhang, Xiao-Dong Wang, Giovanni Targher, Christopher D. Byrne, Yong-Ping Chen, Wei-Jie Yuan, Yan Jin, Ming-Hua Zheng. The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver diseaseNutrition, Metabolism and Cardiovascular Diseases 2021; 31(6): 1822 doi: 10.1016/j.numecd.2021.02.018
5
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, Giovanni Targher, Christopher D. Byrne, Dan-Qin Sun, Ming-Hua Zheng. Association of metabolic dysfunction-associated fatty liver disease with kidney diseaseNature Reviews Nephrology 2022; 18(4): 259 doi: 10.1038/s41581-021-00519-y
6
Anna Di Sessa, Maria Cecilia Russo, Maria Rosaria Arienzo, Giuseppina Rosaria Umano, Domenico Cozzolino, Grazia Cirillo, Stefano Guarino, Emanuele Miraglia del Giudice, Pierluigi Marzuillo. PNPLA3 I148M Polymorphism Influences Renal Function in Children With Obesity and PrediabetesJournal of Renal Nutrition 2022; 32(6): 670 doi: 10.1053/j.jrn.2022.01.007
7
O. V. Smirnova, D. V. Lagutinskaya. Polymorphisms of <i>HSD17B13</i>, <i>GCKR</i>, <i>HFE</i>, and <i>CP</i> as factors of the development of non-alcoholic fatty liver disease and comorbid diseasesMeditsinskiy sovet = Medical Council 2023; (8): 119 doi: 10.21518/ms2022-026
8
Anna Di Sessa, Francesca Lanzaro, Sarah Zarrilli, Vittorio Picone, Stefano Guarino, Emanuele Miraglia del Giudice, Pierluigi Marzuillo. COVID-19 and pediatric fatty liver disease: Is there interplay?World Journal of Gastroenterology 2021; 27(22): 3064-3072 doi: 10.3748/wjg.v27.i22.3064
9
Simona Riccio, Rosa Melone, Caterina Vitulano, Pierfrancesco Guida, Ivan Maddaluno, Stefano Guarino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomicsWorld Journal of Clinical Pediatrics 2022; 11(3): 221-238 doi: 10.5409/wjcp.v11.i3.221
10
Yu-Cheng Lin, Chi-Chien Wu, Yen-Hsuan Ni. New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver DiseaseFrontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.603654
11
Anna Di Sessa, Antonio Paride Passaro, Alberto Maria Colasante, Speranza Cioffi, Stefano Guarino, Giuseppina Rosaria Umano, Alfonso Papparella, Emanuele Miraglia del Giudice, Pierluigi Marzuillo. Kidney damage predictors in children with metabolically healthy and metabolically unhealthy obesity phenotypeInternational Journal of Obesity 2023; 47(12): 1247 doi: 10.1038/s41366-023-01379-1
12
Takashi Motomura, Sriram Amirneni, Ricardo Diaz-Aragon, Lanuza Faccioli, Michelle Malizio, Michael Coard, Zehra Kocas-Kilicarslan, Carla Frau, Nils Haep, Alina Ostrowska, Rodrigo Florentino, Alejandro Soto-Gutierrez. Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic TargetJournal of Personalized Medicine 2021; 11(7): 619 doi: 10.3390/jpm11070619
13
Tochi E. Ukegbu, Judith Wylie-Rosett, Adriana E. Groisman-Perelstein, Pamela M. Diamantis, Jessica Rieder, Mindy Ginsberg, Alice H. Lichtenstein, Nirupa R. Matthan, Viswanathan Shankar. Waist-to-height ratio associated cardiometabolic risk phenotype in children with overweight/obesityBMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-16418-9
14
Francesca Lanzaro, Stefano Guarino, Elisabetta D'Addio, Alessandra Salvatori, Josè Alberto D'Anna, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directionsWorld Journal of Hepatology 2022; 14(6): 1087-1098 doi: 10.4254/wjh.v14.i6.1087
15
Andreas Vadarlis, Sofia Chantavaridou, Georgios Kalopitas, Dimitra Rafailia Bakaloudi, Evangelia Karanika, Eirini Tsekitsidi, Michail Chourdakis. Τhe anthropometric and biochemical profile of pediatric non-alcoholic fatty liver disease: A systematic review and a meta-analysisClinical Nutrition 2022; 41(1): 105 doi: 10.1016/j.clnu.2021.11.016
16
Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, Gyorgy Baffy. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research ImplicationsInternational Journal of Molecular Sciences 2022; 23(21): 13320 doi: 10.3390/ijms232113320
17
Natalia Balassiano Wajsbrot, Nathalie Carvalho Leite, Gil F Salles, Cristiane A Villela-Nogueira. Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspringWorld Journal of Gastroenterology 2022; 28(25): 2890-2899 doi: 10.3748/wjg.v28.i25.2890